NCT00526708

Brief Summary

To evaluate the efficacy of rosuvastatin in Korean dyslipidemia patients with hypertension.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
5,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started May 2007

Shorter than P25 for all trials

Geographic Reach
1 country

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2007

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

September 5, 2007

Completed
5 days until next milestone

First Posted

Study publicly available on registry

September 10, 2007

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2007

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2007

Completed
Last Updated

December 1, 2010

Status Verified

November 1, 2010

Enrollment Period

6 months

First QC Date

September 5, 2007

Last Update Submit

November 30, 2010

Conditions

DyslipidemiaHypertension

Keywords

dyslipidemiahypertensionrosuvastatinefficacyNaturalisticObservational

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Hypertensive hypercholesteromia patients in Korean tertiary care centers

You may qualify if:

  • Hyperlipidemia patients who are prescribed with rosuvastatin 10mg, based on clinical grounds and fulfil the following criteria
  • Over 18 years of age
  • Currently or previously diagnosed with hypertension and receiving medical care

You may not qualify if:

  • Patients already taking other hyperlipidemic agents
  • Patients who do not fulfil the indication criteria for statin therapy
  • Patients who do not have baseline and/or follow-up lipid data to verify the efficacy data

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Research Site

Seoul, Jongro-gu, South Korea

Location

Research Site

Seoul, Kangnam-gu, South Korea

Location

Research Site

Seoul, Songpa-gu, South Korea

Location

MeSH Terms

Conditions

DyslipidemiasHypertension

Condition Hierarchy (Ancestors)

Lipid Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesVascular DiseasesCardiovascular Diseases

Study Officials

  • Hyunah Caroline Choi

    AstraZeneca Korea

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY

Study Record Dates

First Submitted

September 5, 2007

First Posted

September 10, 2007

Study Start

May 1, 2007

Primary Completion

November 1, 2007

Study Completion

November 1, 2007

Last Updated

December 1, 2010

Record last verified: 2010-11

Locations

KR(3)